A Proposed Role for VEGF Isoforms in Sex-Specific Vasculature Development in the Gonad

Reproduction in Domestic Animals

Volumn 43, Issue SUPPL.2, 2008, Pages 310-316

  Bott, R C ^a   Clopton, D T ^a   Cupp, A S ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN;

ANIMAL; ANIMAL MODEL; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GONAD; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GONADS; MALE; MICE; MODELS, ANIMAL; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 58149202438     PISSN: 09366768     EISSN: 14390531     Source Type: Journal    
DOI: 10.1111/j.1439-0531.2008.01179.x     Document Type: Article

References (54)

1. 165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62, 4123-4131.
2. Bott RC, McFee RM, Clopton DT, Toombs C, Cupp AS, 2006: Vascular endothelial growth factor and kinase domain region receptor are involved in both seminiferous cord formation and vascular development during testis morphogenesis in the rat. Biol Reprod 75, 56-67.
3. Brennan J, Karl J, Capel B, 2002: Divergent vascular mechanisms downstream of Sry establish the arterial system in the XY gonad. Dev Biol 244, 418-428.
4. Buehr M, Gu S, McLaren A, 1993: Mesonephric contribution to testis differentiation in the fetal mouse. Development 117, 273-281.
5. Carlsen E, Swan SH, Petersen JH, Skakkebaek NE, 2005: Longitudinal changes in semen parameters in young Danish men from the Copenhagen area. Hum Reprod 20, 942-949.
6. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A, 1996: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
7. Colvin JS, Green RP, Schmahl J, Capel B, Ornitz DM, 2001: Male-to-female sex reversal in mice lacking fibroblast growth factor 9. Cell 104, 875-889.
8. Cupp A, Skinner M, 2005: Embryonic sertoli cell differentiation. in: Griswold M, Skinner M (eds), Sertoli Cell Biology, Vol. 1. Elsevier Academic Press, San Diego, pp. 43-70.
9. Cupp AS, Kim GH, Skinner MK, 2000: Expression and action of neurotropin-3 and nerve growth factor in embryonic and early postnatal rat testis development. Biol Reprod 63, 1617-1628.
10. Cupp AS, Tessarollo L, Skinner MK, 2002: Testis developmental phenotypes in neurotropin receptor trkA and trkC null mutations: role in formation of seminiferous cords and germ cell survival. Biol Reprod 66, 1838-1845.
11. Cupp AS, Uzumcu M, Skinner MK, 2003: Chemotactic role of neurotropin 3 in the embryonic testis that facilitates male sex determination. Biol Reprod 68, 2033-2037.
12. Ferrara N, 2000: VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 11, 617-624.
13. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW, 1996: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
14. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N, 1998: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273, 30336-30343.
15. Gerber H.-P, Hilan K, Ryan A, Kowalski J, Keller G.A, Rangell L, Wright B, Radtke F, Aguet M, Ferrara N, 1999: VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159.
16. Goligorsky MS, Abedi H, Noiri E, Takhtajan A, Lense S, Romanov V, Zachary I, 1999: Nitric oxide modulation of focal adhesions in endothelial cells. Am J Physiol 276, C1271-C1281.
17. Grunstein J, Masbad JJ, Hickey R, Giordano F, Johnson RS, 2000: Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol 20, 7282-7291.
18. He C, Chen X, 2005: Transcription regulation of the vegf gene by the BMP/Smad pathway in the angioblast of zebrafish embryos. Biochem Biophys Res Commun 329, 324-330.
19. Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M, 1998: Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A 95, 9349-9354.
20. Huminiecki L, Chan H, Lui S, Poulsom R, Stamp G, Harris A, Bicknell R, 2001: Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection. Mol Human Reprod 7, 255-264.
21. Jeays-Ward K, Hoyle C, Brennan J, Dandonneau M, Alldus G, Capel B, Swain A, 2003: Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad. Development 130, 3663-3670.
22. Jia H, Bagherzadeh A, Hartzoulakis B, Jarvis A, Lohr M, Shaikh S, Aqil R, Cheng L, Tickner M, Esposito D, Harris R, Driscoll PC, Selwood DL, Zachary IC, 2006: Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling. J Biol Chem 281, 13493-13502.
23. Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, Fujisawa H, 1999: A requirement for neuropilin-1 in embryonic vessel formation. Development 126, 4895-4902.
24. Klagsbrun M, Eichmann A, 2005: A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev 16, 535-548.
25. Korpelainen E, Karkkainen M, Tenhunen A, Lakso M, Rauvala H, Vierula M, Parvinen M, Alitalo K, 1998: Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. J Cell Biol 143, 1705-1712.
26. Magre S, Jost A, 1991: Sertoli cells and testicular differentiation in the rat fetus. J Electron Microsc Tech 19, 172-188.
27. Martineau J, Nordqvist K, Tilmann C, Lovell-Badge R, Capel B, 1997: Male-specific cell migration into the developing gonad. Curr Biol 7, 958-968.
28. Merchant-Larios H, Moreno-Mendoza N, Buehr M, 1993: The role of the mesonephros in cell differentiation and morphogenesis of the mouse fetal testis. Int J Dev Biol 37, 407-415.
29. Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M, 1999: Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 146, 233-242.
30. Millauer B, Shauver L, Plate K, Risau W, Ullrich A, 1994: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579.
31. Miquerol L, Langille BL, Nagy A, 2000: Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127, 3941-3946.
32. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN, 2000: Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci U S A 97, 10972-10977.
33. Mueller MD, Vigne JL, Pritts EA, Chao V, Dreher E, Taylor RN, 2003: Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells. Fertil Steril 79, 386-392.
34. Mukouyama YS, Gerber HP, Ferrara N, Gu C, Anderson DJ, 2005: Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development 132, 941-952.
35. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L, 2006: VEGF receptor signalling - in control of vascular function. Nat Rev 7, 359-371.
36. Pan Q, Chathery Y, Wu Y, Rathore N, Tong RK, Peale F, Bagri A, Tessier-Lavigne M, Koch AW, Watts R. J, 2007: Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J Biol Chem 282, 24049-24056.
37. Perrin RM, Konopatskaya O, Qiu Y, Harper S, Bates DO, Churchill AJ, 2005: Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 48, 2422-2427.
38. Pohlmann R, Clopton D, McFee R, Rozell T, Cupp A, 2004: Inhibition of Vascular Endothelial Growth Factor (VEGF) Signaling blocks follicle progression in the perinatal rat ovary. J Anim Sci 82, 233.
39. Qiu YBH, Weeraperuma S, Wratting D, Murphy D, Neal CR, Bates DO, Harper SJ, 2008: Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF165b. FASEB J 22, 1104-1112.
40. Ricci G, Catizone A, Innocenzi A, Galdieri M, 1999: Hepatocyte growth factor (HGF) receptor expression and role of HGF during embryonic mouse testis development. Dev Biol 216, 340-347.
41. Ross AJ, Tilman C, Yao H, MacLaughlin D, Capel B, 2003: AMH induces mesonephric cell migration in XX gonads. Mol Cell Endocrinol 211, 1-7.
42. Ruhrberg C, 2003: Growing and shaping the vascular tree: multiple roles for VEGF. BioEssays 25, 1052-1060.
43. Schmahl J, Eicher EM, Washburn LL, Capel B, 2000: Sry induces cell proliferation in the mouse gonad. Development 127, 65-73.
44. Schweda F, Blumberg FC, Schweda A, Nabel C, Holmer SR, Riegger GA, Pfeifer M, Kramer BK, 2000: Effects of chronic hypoxia on renal PDGF-A, PDGF-B, and VEGF gene expression in rats. Nephron 86, 161-166.
45. Shu X, Wu W, Mosteller RD, Broek D, 2002: Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol Cell Biol 22, 7758-7768.
46. Skakkebaek NE, 2004: Testicular dysgenesis syndrome: new epidemiological evidence. Int J Androl 27, 189-191.
47. Takahashi T, Nakamura F, Jin Z, Kalb RG, Strittmatter SM, 1998: Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors. Nat Neurosci 1, 487-493.
48. Uzumcu M, Dirks KA, Skinner MK, 2002a: Inhibition of platelet-derived growth factor actions in the embryonic testis influences normal cord development and morphology. Biol Reprod 66, 745-753.
49. Uzumcu M, Westfall SD, Dirks KA, Skinner MK, 2002b: Embryonic testis cord formation and mesonephric cell migration requires the phosphotidylinositol 3-kinase signaling pathway. Biol Reprod 67, 1927-1935.
50. Veikkola T, Alitalo K, 1999: VEGF's receptors and angiogenesis. Semin Cancer Biol 9, 211-220.
51. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH, 1994: Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 269, 26988-26995.
52. 165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64, 7822-7835.
53. Yao HH, Matzuk MM, Jorgez CJ, Menke DB, Page DC, Swain A, Capel B, 2004: Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 230, 210-215.
54. Yao HH, Aardema J, Holthusen K, 2006: Sexually dimorphic regulation of inhibin beta B in establishing gonadal vasculature in mice. Biol Reprod 74, 978-983.